A paired comparison of travoprost and latanoprost on IOP and conjunctival hyperemia

被引:0
|
作者
McNeal, E
Yablonski, ME
机构
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
2455
引用
收藏
页数:1
相关论文
共 50 条
  • [21] In Vitro Toxicity of Preservative-Free Tafluprost and Preserved Latanoprost, Travoprost and Bimatoprost: A Study on Conjunctival Epithelial Cells
    Brasnu, E.
    Liang, H.
    Brignole-Baudouin, F.
    Riancho, L.
    Guenoun, J. -M.
    Warnet, J. -M.
    Baudouin, C.
    PROCEEDINGS OF THE 7TH INTERNATIONAL SYMPOSIUM ON OCULAR PHARMACOLOGY AND THERAPEUTICS, 2008, : 93 - +
  • [22] In vitro effects of preservative-free tafluprost and preserved latanoprost, travoprost, and bimatoprost in a conjunctival epithelial cell line
    Brasnu, Emmanuelle
    Brignole-Bauclouin, Francoise
    Riancho, Luisa
    Guenoun, Jean-Marc
    Warnet, Jean-Michel
    Baudouin, Christophe
    CURRENT EYE RESEARCH, 2008, 33 (04) : 303 - 312
  • [23] Comparison of the Effect of Latanoprost on IOP Lowering in Two Strains of Normotensive Rat
    Vezina, Mark
    Li, Christian
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [24] Comparison of the effects of latanoprost and travoprost on intraocular pressure in chronic angle-closure glaucoma
    Chen, Mei-Ju
    Chen, Yen-Cheng
    Chou, Ching-Kuang
    Hsu, Wen-Ming
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2006, 22 (06) : 449 - 454
  • [25] Comparison of diurnal intraocular pressure control by latanoprost versus travoprost - Results of an observational survey
    Denis, Philippe
    Launois, Robert
    Devaux, Marion
    Berdeaux, Gilles
    CLINICAL DRUG INVESTIGATION, 2006, 26 (12) : 703 - 714
  • [26] Comparison between Latanoprost, Travoprost, and Tafluprost in reducing intraocular pressure fluctuations in patients with glaucoma
    Faseeh, Ahmed Essam
    Allam, Riham S. H. M.
    Shalash, Ahmed B.
    Abd Elmohsen, Mai Nasser
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2021, 31 (06) : 3018 - 3026
  • [27] The efficacy and safety of bimatoprost/timolol maleate, latanoprost/timolol maleate, and travoprost/timolol maleate fixed combinations on 24-h IOP
    Yilmaz, Suzan Guven
    Degirmenci, Cumali
    Karakoyun, Yunus Emre
    Yusifov, Emil
    Ates, Halil
    INTERNATIONAL OPHTHALMOLOGY, 2018, 38 (04) : 1425 - 1431
  • [28] The efficacy and safety of bimatoprost/timolol maleate, latanoprost/timolol maleate, and travoprost/timolol maleate fixed combinations on 24-h IOP
    Suzan Guven Yilmaz
    Cumali Degirmenci
    Yunus Emre Karakoyun
    Emil Yusifov
    Halil Ates
    International Ophthalmology, 2018, 38 : 1425 - 1431
  • [29] Comparative In Vitro Toxicology Study of Travoprost Polyquad-preserved, Travoprost BAK-preserved, and Latanoprost BAK-preserved Ophthalmic Solutions on Human Conjunctival Epithelial Cells
    Brignole-Baudouin, Francoise
    Riancho, Luisa
    Liang, Hong
    Baudouin, Christophe
    CURRENT EYE RESEARCH, 2011, 36 (11) : 979 - 988
  • [30] IOP-lowering efficacy and safety of travoprost compared to latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.
    Netland, PA
    Landry, T
    Silver, LH
    Sullivan, EK
    Andrew, R
    Weiner, AL
    Bergamini, MVW
    Robertson, SM
    Mallick, S
    Davis, AA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S556 - S556